Clinical and neuroimmunologic characteristics of late onset of schizophrenia and schizophrenia-like psychoses

Abstract

BACKGROUND. After dementia and depression, schizophrenia-like psychoses with very late onset is the largest diagnostic group among late onset mental diseases. Last studies have shown the clinical heterogeneity of these psychoses.

AIM. Determine the clinical forms of late-onset psychoses, their corresponding immunological correlates and their diagnostic significance.

MATERIAL AND METHODS. 25 patients with late onset psychoses, mean age 64.8±6.0 years, age of onset of the disease 69.8±7.99 years were examined. The control group consisted of 14 people (9 women, 5 men) without mental disorders, mean age 64.8±6.0 years. Clinical and psychopathological examination was carried out, and assessment using psychometric scales (PANSS, HAMD, MoCA, MMSE). Immunological parameters were assessed: leukocyte elastase, α1-proteinase inhibitor, their ratio — proteinase inhibitor index, levels of autoantibodies to neuroantigens — protein S100b and basic myelin protein. Cluster analysis, as well as the t-criteria, Kruskal–Wallis, U Manna–Withney methods were used as the main approach to statistical data processing

RESULTS. Three groups of patients were identified — a group with acute polymorphic psychotic symptoms, characterized by the severity of the pathological process, heterogeneous psychotic symptoms, pronounced cognitive decline, lack of significant dynamics in the treatment process; a group of patients with a predominance of “involutional color” of psychosis, characterized by a continuous course with incomplete remission and little response to therapy; group of affective-delusional psychoses with paroxysmal course, low severity of cognitive impairment, good response to therapy.

CONCLUSION. The clinical heterogeneity of the group of late manifesting psychoses was determined, the immunological features inherent in each group, their prognostic significance were highlighted.

Keywords

late onset schizophrenia / very late onset schizophrenia like psychosis / involutional psychosis / markers of inflammation / cluster analysis

References

[1] Reeves S.J., Sauer J., Stewart R. et al. Increased first-contact rates for very-late-onset schizophrenia-like psychosis in African- and Caribbean-born elders. Br. J. Psychiatry. 2001; 179: 172–174. DOI: 10.1192/bjp.179.2.172.

[2] Reeves S.J., Sauer J., Stewart R. et al. Increased first-contact rates for very-late-onset schizophrenia-like psychosis in African- and Caribbean-born elders // Br. J. Psychiatry. 2001. Vol. 179. P. 172–174. DOI: 10.1192/bjp.179.2.172.

[3] Howard R., Rabins P.V., Seeman M.V., Jeste D.V. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am. J. Psychiatry. 2000; 157 (2): 172–178. DOI: 10.1176/appi.ajp.157.2.172.

[4] Howard R., Rabins P.V., Seeman M.V., Jeste D.V. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group // Am. J. Psychiatry. 2000. Vol. 157. N. 2. P. 172–178. DOI: 10.1176/appi.ajp.157.2.172.

[5] Suen Y.N., Wong S.M.Y., Hui C.L.M. et al. Late-onset psychosis and very-late-onset-schizophrenia-like-psychosis: an updated systematic review. Int. Rev. Psychiatry. 2019; 31 (5–6): 523–542. DOI: 10.1080/09540261.2019.1670624.

[6] Suen Y.N., Wong S.M.Y., Hui C.L.M. et al. Late-onset psychosis and very-late-onset-schizophrenia-like-psychosis: an updated systematic review // Int. Rev. Psychiatry. 2019. Vol. 31. N. 5–6. P. 523–542. DOI: 10.1080/09540261.2019.1670624.

[7] Valova O.A., Medvedev A.V. Pozdnie bredovye psikhozy v svete semeino-geneticheskogo issledovaniya. Sb. VNPZ AMN SSSR, 1991. 37–51. (In Russ.)

[8] Валова О.А., Медведев А.В. Поздние бредовые психозы в свете семейно-генетического исследования / Сб. ВНПЗ АМН СССР, 1991. С. 37–51.

[9] Jeste D.V., Harris M.J., Krull A. et al. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am. J. Psychiatry. 1995; 152 (5): 722–730. DOI: 10.1176/ajp.152.5.722.

[10] Jeste D.V., Harris M.J., Krull A. et al. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia // Am. J. Psychiatry. 1995. Vol. 152. N. 5. P. 722–730. DOI: 10.1176/ajp.152.5.722.

[11] Talaslahti T., Alanen H.M., Hakko H. et al. Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia. Int. J. Geriatr. Psychiatry. 2015; 30 (5): 453–459. DOI: 10.1002/gps.4159.

[12] Talaslahti T., Alanen H.M., Hakko H. et al. Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia // Int. J. Geriatr. Psychiatry. 2015. Vol. 30. N. 5. P. 453–459. DOI: 10.1002/gps.4159.

[13] Talaslahti T., Alanen H.M., Hakko H. et al. Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis. Int. J. Geriatr. Psychiatry. 2016; 31 (4): 355–360. DOI: 10.1002/gps.4333.

[14] Talaslahti T., Alanen H.M., Hakko H. et al. Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis // Int. J. Geriatr. Psychiatry. 2016. Vol. 31. N. 4. P. 355–360. DOI: 10.1002/gps.4333.

[15] Klyushnik T.P., Androsova L.V., Zozulya S.A. et al. Comparative analysis of inflammatory markers in endogenous and non-psychotic mental disorders. Siberian Herald of Psychiatry an Addiction Psychiatry. 2018; 2 (99): 64–69. (In Russ.) DOI: 10.26617/1810-3111-2018-2(99)-64-6.

[16] Клюшник Т.П., Андросова Л.В., Зозуля С.А. и др. Сравнительный анализ воспалительных маркёров при эндогенных и непсихотических психических расстройствах // Сибирский вестник психиатрии и наркологии. 2018; 2 (99): 64–69. DOI: 10.26617/1810-3111-2018-2(99)-64-6.

[17] Androsova L.V., Mihajlova N.M., Zozulya S.A., Dupin A.M., Klyushnik T.P. Inflammatory markers in schizophrenia in aged. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014; 12: 59–63. (In Russ.) DOI: 10.17116/jnevro201411412160-64.

[18] Андросова Л.В., Михайлова Н.М., Зозуля С.А. и др. Маркёры воспаления при шизофрении позднего возраста // Журнал неврологии и психиатрии им. С.С. Корсакова. 2014. Т. 12. С. 59–63. DOI: 10.17116/ jnevro201411412160-64.

[19] Lindenmayer J.P., Bernstein-Hyman R., Grochowski S., Bark N. Psychopathology of Schizophrenia: initial validation of a 5-factor model. Psychopathology. 1995; 28 (1): 22–31. DOI: 10.1159/000284896.

[20] Lindenmayer J.P., Bernstein-Hyman R., Grochowski S., Bark N. Psychopathology of Schizophrenia: initial validation of a 5-factor model // Psychopathology. 1995. Vol. 28. N. 1. P. 22–31. DOI: 10.1159/000284896.

[21] Dotsenko V.L., Neshkova E.A., Yarovaya G.A. Detection of human leukocyte elastase from a plasma α1-proteinase inhibitor complex by its enzymatic activity with synthetic substrate. Voprosy meditsinskoi khimii. 1994; 40 (3): 20–25. (In Russ.)

[22] Доценко В.Л., Нешкова Е.А., Яровая Г.А. Выявление лейкоцитарной эластазы человека из комплекса с плазменным α1-протеиназным ингибитором по её энзиматической активности с синтетическим субстратом // Вопросы медицинской химии. 1994. Т. 40. №3. С. 20–25.

[23] Nartikova V.F., Paskhina T.S. A method for estimation of α1-antitrypsin and of α2-macroglobulin in human blood serum (plasma) in normal state and under some pathological conditions. Voprosy meditsinskoi khimii. 1979; 25 (4): 494–499. (In Russ.)

[24] Нартикова В.Ф., Пасхина Т.С. Унифицированный метод определения активности α1-антитрипсина и α2-макроглобулина в сыворотке (плазме) крови человека // Вопросы медицинской химии. 1979. Т. 25. №4. С. 494–502.

RIGHTS & PERMISSIONS

Pochueva V.V., Kolychalov I.V., Androsova L.V.